Aleksander Krag

AI Summary

→ WHAT IT COVERS Prof Aleksander Krag, hepatologist and European Liver Society former president, explains that roughly 30% of the global population has steatotic liver disease — most undetected until advanced stages. He covers how fat accumulates in the liver, the role of alcohol and metabolic dysfunction, fibrosis progression timelines, screening methods, and two newly FDA-approved treatments. → KEY INSIGHTS - **Silent progression and screening triggers:** Steatotic liver disease produces no symptoms until advanced stages, when fluid accumulation, vomiting blood, or brain dysfunction appear. People with type 2 diabetes, grade 3 obesity, or persistently elevated liver function tests should request a FIB-4 index test from their GP — a simple calculation using age, two liver enzymes, and platelet count that flags fibrosis risk before damage becomes irreversible. - **Alcohol underreporting distorts risk:** Self-reported alcohol intake significantly undercounts consumption. A blood metabolite called phosphatidylethanol, measurable via mass spectrometry, reveals true alcohol exposure. Studies using this marker found up to 38% of patients classified as metabolic-only liver disease actually belonged in higher alcohol-exposure categories. Individuals should count weekly units honestly, as even moderate drinking accelerates fibrosis progression from roughly six years per stage to three years. - **Fibrosis, not fat, is the liver danger signal:** Having more than 5% liver fat alone rarely causes liver-specific harm. The clinical risk comes from fibrosis — scarring that disrupts blood flow, protein synthesis, and detoxification. Fibrosis is graded 0–4, with grade 4 representing cirrhosis. Crucially, even advanced fibrosis is reversible with intervention, including at cirrhosis stage, overturning the previous medical consensus that scarring was permanent. - **Two FDA-approved drugs target liver fibrosis directly:** Resmetirom (Rezdiffra) corrects liver-specific hypothyroidism to exert anti-fibrotic effects without affecting weight or blood sugar. Semaglutide (Wegovy/Ozempic), a GLP-1 agonist, reduces steatosis, inflammation, and fibrosis through both metabolic improvements and direct liver receptors in sinusoidal endothelial cells. Both are approved for significant fibrosis in conjunction with diet and exercise, and may be combined when phenotype warrants it. - **Abdominal circumference is the single most predictive home measurement:** Central obesity correlates more strongly with liver disease risk than BMI. Measuring waist circumference at home provides a meaningful individual risk signal, with reference ranges varying by sex and ethnicity — Asian populations have lower thresholds. This single metric outperforms BMI because subcutaneous fat on hips carries far lower metabolic risk than visceral abdominal fat surrounding the liver and gut. - **Coffee is protective; excess fruit fructose is not:** Consistent evidence across decades links regular coffee consumption to lower liver fat and better liver outcomes, regardless of mechanism. Conversely, fructose from fruit is metabolized almost exclusively into triglycerides in the liver. In individuals with caloric surplus, insulin resistance, or obesity, high fruit intake adds hepatic fat load. In energy-balanced, metabolically healthy individuals, moderate fruit intake poses minimal liver risk. → NOTABLE MOMENT When researchers measured a precise alcohol metabolite in blood rather than relying on self-report, they found that over half of patients categorized in the intermediate alcohol group actually belonged in the high-risk alcohol-related liver disease category — suggesting standard clinical databases may be dramatically underestimating alcohol's role in liver disease prevalence. 💼 SPONSORS [{"name": "Function Health", "url": "https://functionhealth.com/simonhill"}, {"name": "iMate", "url": "https://imatehealth.com"}, {"name": "Momentous", "url": "https://livemomentous.com"}, {"name": "Whoop", "url": "https://join.whoop.com/simon"}, {"name": "Swim Club", "url": "https://swimclub.co/theproof"}, {"name": "Eight Sleep", "url": "https://8sleep.com/theproof"}] 🏷️ Liver Disease, Steatotic Liver Disease, Fibrosis, GLP-1 Agonists, Metabolic Health, Alcohol and Health